These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4739427)

  • 1. [Activity of human growth hormone (HGH) in serum following insulin stimulation in radioiodine treated toxic adenoma and Basedow disease].
    Braun KP; Glanzmann C; Nilson K; Horst W
    Klin Wochenschr; 1973 Feb; 51(3):123-6. PubMed ID: 4739427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antagonistic action of growth hormone (HGH) in the serum following insulin stimulation in decompensated toxic adenoma and Basedow's disease].
    Braun KP; Glanzmann C; Horst W
    Dtsch Med Wochenschr; 1972 Apr; 97(14):579-80. PubMed ID: 5067301
    [No Abstract]   [Full Text] [Related]  

  • 3. [Regulation mechanisms of the pituitary-thyroid axis in normal subjects and patients with Graves' disease using a highly sensitive TSH assay].
    Takagi S; Yamauchi K; Mori Y; Tanaka H; Miura Y; Takatsuki K; Tomita A; Funahashi H; Mizuno S; Ishizuki Y
    Kaku Igaku; 1986 Aug; 23(8):1043-53. PubMed ID: 3784128
    [No Abstract]   [Full Text] [Related]  

  • 4. [Suppressibility of the thyroid function following radioiodine therapy of hyperthyroidism. When is Basedow-Graves disease completely cured?].
    Fazakas S; Kiss B; Petrányi G
    Orv Hetil; 1972 May; 113(20):1059-61. PubMed ID: 5067474
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of plasma thyrotrophin response to thyrotrophin releasing hormone in Graves' disease and in hyperactive thyroid adenoma before and after treatment.
    Faglia G; Ferrari C; Beck-Peccoz P; Ambrosi B; Spada A; Travaglini P; Paracchi A
    Folia Endocrinol; 1973 Aug; 26(4):245-56. PubMed ID: 4203132
    [No Abstract]   [Full Text] [Related]  

  • 6. [Study of the degradation of labelled thyroxine in patients with hyperthyroidism treated with radioactive iodine].
    Simonin R; Argémi B; Alland A; Paulin R; Bernard PJ
    Ann Endocrinol (Paris); 1970; 31(3):363-6. PubMed ID: 4989456
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment of the so-called toxic adenoma of the thyroid gland].
    Uthgenannt H; Adlung J; Brinkhoff H
    Fortschr Geb Rontgenstr Nuklearmed; 1971 Sep; 115(3):340-7. PubMed ID: 5110046
    [No Abstract]   [Full Text] [Related]  

  • 8. [Toxic adenoma. Study of 35 cases].
    Barceló Lucerga B; Alcañiz Ferrando J; Ortiz Berrocal J; Salto Hernández L
    Rev Iber Endocrinol; 1971; 18(106):369-83. PubMed ID: 5171341
    [No Abstract]   [Full Text] [Related]  

  • 9. [The development of adenoma and atypical adenoma following I-131 treatment of thyroid gland diseases].
    Zukschwerdt L; Bay V; Gusek W
    Zentralbl Chir; 1967; 92(26a Pt 1):1319-24. PubMed ID: 5631684
    [No Abstract]   [Full Text] [Related]  

  • 10. 306 cases of toxic adenoma: clinical aspects, findings in radioiodine diagnostics, radiochromatography and histology; results of 131-I and surgical treatment.
    Horst W; Rösler H; Schneider C; Labhart A
    J Nucl Med; 1967 Jul; 8(7):515-28. PubMed ID: 4166326
    [No Abstract]   [Full Text] [Related]  

  • 11. [Role of the hypophysis in thyroid pathology].
    Scazziga BR; Lemarchand-Béraud T
    Schweiz Med Wochenschr; 1968 Feb; 98(5):148-56. PubMed ID: 5695037
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum L-triiodothyronine radioimmunoassay: measurements in normal subjects and in thyroid patients.
    Beckers C; Cornette C; Thalasso M
    Int J Nucl Med Biol; 1974 Feb; 1(3):121-9. PubMed ID: 4406090
    [No Abstract]   [Full Text] [Related]  

  • 13. Pituitary response to hypoglycemia in pituitary diseases.
    Genazzani AR; Ruedi B; Aubert ML; Felber JP
    Horm Metab Res; 1972 Nov; 4(6):470-7. PubMed ID: 4655503
    [No Abstract]   [Full Text] [Related]  

  • 14. Assessment of somatotrophic hypophyseal function in acromegalic patients by estimation of serum growth hormone before and after surgical treatment.
    Rohde W; Knappe G; Mennig H; Unger RR
    Horm Res; 1973; 4(3):129-40. PubMed ID: 4748470
    [No Abstract]   [Full Text] [Related]  

  • 15. [The iodine dynamics in autonomous hormone-producing thyroid gland adenoma. Toxic adenoma].
    Grebe SF
    Nucl Med (Stuttg); 1969 Apr; 8(1):89-94. PubMed ID: 4183630
    [No Abstract]   [Full Text] [Related]  

  • 16. [Secretion of human growth hormone (HGH). 1. Basic study of HGH determination and serum HGH in normal subjects].
    Kato Y
    Nihon Naibunpi Gakkai Zasshi; 1972 Aug; 48(5):343-51. PubMed ID: 4673032
    [No Abstract]   [Full Text] [Related]  

  • 17. Anaplastic thyroid cancer twelve years after radioiodine therapy.
    Baker HW
    Cancer; 1969 Apr; 23(4):885-90. PubMed ID: 5818522
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the diagnosis and treatment of diseases of the thyroid gland with radioactive iodine].
    Egorov PI; Tsfasman AZ
    Ter Arkh; 1967 Mar; 39(3):5-9. PubMed ID: 4894050
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical significance of compensated autonomic thyroid-gland adenoma].
    Rainer O
    Wien Med Wochenschr; 1976 Jul; 126(28-31):437-40. PubMed ID: 1036641
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of thyroglobulin synthesis and secretion (second of two parts).
    Van Herle AJ; Vassart G; Dumont JE
    N Engl J Med; 1979 Aug; 301(6):307-14. PubMed ID: 88013
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.